Oklahoma Center of ImmunoEngineering supports immunology research and data science
Official title: Oklahoma Center of ImmunoEngineering (OCIE)
Funded at University of Oklahoma · NIH-11269423 · Data updated 2026-11-12
A center in Oklahoma helps immunology researchers work with big data to understand immune-related diseases and to develop scientists through career support.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma NIH-funded |
| Lab location | 1 site (Norman, United States) |
| Project start | May 15, 2026 |
| Project end | January 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $475,041 |
| NIH project number | 1P20GM162339-01 |
| Project ID | NIH-11269423 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers, clinicians, and patients may benefit indirectly as the center accelerates discovery and translation of immunoengineering therapies.
✕Less likely to help
Patients may not experience direct benefit during the grant period while the center is primarily building research infrastructure and processes.
What this research studies
The OCIE Administrative Core will lead and organize the center, manage finances, and oversee two Research Cores: Immunomodulation Technology and Omics Data Science. It will recruit and mentor Research Project Leaders to advance immunoengineering projects. The core includes a dedicated Administrative/Financial Manager and processes to monitor progress, convene advisory boards, and implement recommendations. Through infrastructure development and strong coordination, OCIE aims to accelerate discoveries that could improve immune-related health outcomes.
Why it matters
Potential benefit: If successful, OCIE could speed up immunology research and turn findings into new therapies or diagnostic tools for immune-related diseases.
How similar studies have gone: CoBRE/Center of Biomedical Research Excellence-style centers have previously shown that structured cores and mentorship accelerate translational immunology research.
Where this research is happening
-
University of Oklahoma
Norman, United States Active
Researchers
- Principal investigator: Chen, Wei R. — University of Oklahoma
- Study coordinator: Chen, Wei R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.